This Startup Is Democratizing Genomics Using Blockchain and ML

This Startup Is Democratizing Genomics Using Blockchain and ML

Blockchain Startups
August 22, 2019 Editor's Desk
398
With the vision of providing data-owners, researchers and pharmaceutical companies the ability to securely share, store, analyze DNA data quickly and efficiently and at any scale came into being Shivom. Shivom is a biotechnology data and analysis company and what makes this organization more advanced and special is the fact that they are utilizing innovative technologies
Genomic Blockchain Shivom

With the vision of providing data-owners, researchers and pharmaceutical companies the ability to securely share, store, analyze DNA data quickly and efficiently and at any scale came into being Shivom.

Shivom is a biotechnology data and analysis company and what makes this organization more advanced and special is the fact that they are utilizing innovative technologies such as blockchain and machine-learning algorithms, to be able to democratize genomics.

Shivom believes that the unique combination of their in-depth knowledge for genomics, mixed with deep-rooted backgrounds in cryptography and AI is essential in the democratization of genomics and healthcare data.

Alex Schumacher the CEO of Shivom who is also a Geneticist & Futurologist believes in revolutionizing Healthcare and he is of the opinion that science is indeed a form of art and by using multi-omics, blockchain technology, artificial intelligence, IoT, and smart devices, he believes that it is time to innovate now in precision medicine, disease prevention and life-style businesses.

“Through action & collaboration, we can create the future, to be the next big enabler and driver of an intelligent and healthier world”. He further added.

But as consumers why should we switch to Shivom?  What it has in store for the consumers is something we look forward to.

So here’s why: Shivom provides consumers and enterprises with various services from personalized reporting and DNA kits to our DNA data search and marketplace. It also increases awareness and sales of your genetic test kits and reports. Their shop is quickly becoming the go-to place for consumers to discover genetic testing products and services. 

Today, the major threat facing the direct-to-consumer genetic testing market is the absence of privacy. Currently, privacy has been the main concern, and a small number of industry leaders have a stiff monopoly on this genetic data.

But not with Shivom because unlike other companies they use blockchain technology so that data custodians and consumers enjoy the ability to have control and value of their data. Meaning, this data never leaves the platform, and you may choose to delete it at any time.

Shivom maintains a dynamic consent technology that permits data owners and custodians to choose who comes in contact with their data.

So this concludes that this is surely a secure platform where genomic researchers can perform data analysis and research without any security compromises.

Shivom also serves as a great, trusted marketplace that has led to a potential increase the number of consumers because secure technology is always the one to grab eye-balls! 

They have set up one of the best ways of promoting healthcare products and services. As researchers complete studies, analysis and or digital trials, revenue generated from those solutions flow back to the data owners in OMX tokens. These tokens are then used within their marketplace to purchase health products from our direct-to-consumer partners.

While this start-up definitely earns brownie points for their one of kind approach towards the healthcare business, while using advanced secure technologies like blockchain it can also be a great place to take your career a step ahead by joining Shivom’s vibrant community of professionals.

Shivom offers you a useful learning and work experience in healthcare’s most fast-paced and exciting space – Genomics!“Shivom provided me with a window of new experiences within the blockchain and artificial intelligence space.” said Darrol Baker who is the Head of Bioinformatics at Shivom.

Healthcare and specifically genomics have to go through a major uplifting transformation by embracing the idea of innovative technologies. Now that a start-up like Shivom has readily done so, who wish to create global impact in the field of medicine the future of healthcare seems to be in the right hands. With the commitment to providing quality genomic products and services we all can look forward to their rising success. 

Related posts

Add a comment